Bacterial self-healing concrete — microbial calcite precipitation (Bacillus subtilis)

Product · Materials Science

Product · InnDex 15 · Evidence provided · High specification risk

Concrete with embedded Bacillus subtilis spores that precipitate calcite to self-heal cracks up to ~1 mm.

Bacillus subtilis spores are added to fresh concrete mix. When cracks form and water enters, dormant spores germinate and metabolize to produce calcium carbonate, sealing micro-fractures. Addresses concrete's inherent brittleness and maintenance burden from crack propagation. Lab results (M20–M30 grade) show 32% compressive strength recovery in controlled cube/cylinder tests, but no field trials, pilots, or commercial products exist.

Bacillus subtilis spores mixed into fresh concrete germinate when water enters cracks, metabolising to produce calcium carbonate that seals micro-fractures — a mechanism demonstrated in controlled lab tests at M20–M30 grade with 32% compressive strength recovery reported in cube and cylinder specimens. That result represents genuine progress from concept to measured laboratory performance, and the record carries a provided evidence point reflecting that. The constraint that matters most for a structural specifier is what the 32% figure does not tell you: it is a controlled-environment lab result, not a field performance measurement, and neither crack healing repeatability across a service life nor behaviour under the heterogeneity, thermal cycling and aggressive chemistry of real structural concrete has been tested. The spores require water and oxygen ingress to activate, meaning the trigger conditions are unpredictable and crack width is limited to approximately 1 mm — larger fractures and structural separation are outside scope. EN 206 and ACI 318 do not recognise self-healing mechanisms, so there is no code pathway for specification today. Long-term spore dormancy over a 50-year service life is undemonstrated, and cost premium over standard concrete is unknown. This is a credible research direction with meaningful lab evidence; it needs field pilots, durability data and a regulatory pathway before it can be considered for anything beyond exploratory material trials.

Strengths

• Reduces maintenance and repair costs for crack-related structural degradation
• Extends concrete service life by autonomously healing micro-fractures without external intervention
• Uses metabolic process rather than chemical additives, aligning with circular/bio-based material ethos
• Potential to lower embodied carbon if spore cultivation is low-impact

Considerations

• Crack closure performance limited to ~1 mm; larger cracks or structural damage remain unaddressed (moderate)
• Requires sustained water and oxygen ingress to trigger germination—timing and conditions unpredictable in real structures (high)
• Adds biological material to concrete; long-term viability of spore dormancy over 50+ year service life unvalidated (high)
• Adds material and manufacturing complexity; cost premium over standard concrete unknown (moderate)

Risks

• No field deployment data; 32% strength recovery measured in controlled lab cubes—real-world structural concrete behaviour (heterogeneity, thermal cycling, aggressive environments) untested (critical)
• Regulatory and durability standards (EN 206, ACI 318) do not recognise or validate self-healing mechanisms; certification pathway unclear (high)
• Dormant spore stability during concrete hydration, curing, and long-term storage not demonstrated at scale (high)
• Healing rate and repeatability unknown; unclear if one 'healing cycle' per crack or if multiple cracks can be healed over structure lifetime (moderate)
• Microbial activity sensitive to pH, moisture, nutrient availability—conditions in hardened concrete matrix may inhibit or enable unwanted side reactions (moderate)

Performance

• Max crack width healed: ~0.97–1.0 mm (lab)
• Compressive strength gain: 9–18% at 7–14 days; ~1% at 28 days
• Healing time: 21 days under optimal curing
• Technology readiness: TRL 4–5 (lab only, no field trial)

Reality check

Peer-reviewed lab data exists (Scientific Reports 2025) with repeatable results on small specimens. However, no evidence of field deployment, pilot-scale validation, commercial viability, cost analysis, or long-term field durability. Spore viability under transport, storage, and in-service wet/dry cycling remains undemonstrated. Scale-up barriers (mixing uniformity, spore dormancy during curing, activation reliability) are stated but not solved. Claims of 'sustainable' are marketing-adjacent; embodied carbon and production cost vs. conventional repair are not quantified.

#self-healing #microbial #durability #crack-repair #sustainability #concrete

Source